UNIVERSAL HEALTH SERVICES-B (UHS) Fundamental Analysis & Valuation

NYSE:UHS • US9139031002

Current stock price

184.52 USD
-0.57 (-0.31%)
Last:

This UHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UHS Profitability Analysis

1.1 Basic Checks

  • UHS had positive earnings in the past year.
  • In the past year UHS had a positive cash flow from operations.
  • UHS had positive earnings in each of the past 5 years.
  • UHS had a positive operating cash flow in each of the past 5 years.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.59%, UHS belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
  • UHS has a Return On Equity of 20.46%. This is amongst the best in the industry. UHS outperforms 89.00% of its industry peers.
  • UHS has a Return On Invested Capital of 12.52%. This is amongst the best in the industry. UHS outperforms 87.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 8.85%.
  • The last Return On Invested Capital (12.52%) for UHS is above the 3 year average (10.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROIC 12.52%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • UHS has a better Profit Margin (8.57%) than 90.00% of its industry peers.
  • UHS's Profit Margin has been stable in the last couple of years.
  • UHS has a Operating Margin of 11.48%. This is amongst the best in the industry. UHS outperforms 82.00% of its industry peers.
  • In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
Industry RankSector Rank
OM 11.48%
PM (TTM) 8.57%
GM N/A
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5

2. UHS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UHS is still creating some value.
  • The number of shares outstanding for UHS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, UHS has less shares outstanding
  • Compared to 1 year ago, UHS has an improved debt to assets ratio.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • UHS has an Altman-Z score of 3.03. This indicates that UHS is financially healthy and has little risk of bankruptcy at the moment.
  • UHS has a Altman-Z score of 3.03. This is in the better half of the industry: UHS outperforms 67.00% of its industry peers.
  • UHS has a debt to FCF ratio of 5.60. This is a neutral value as UHS would need 5.60 years to pay back of all of its debts.
  • UHS has a Debt to FCF ratio (5.60) which is comparable to the rest of the industry.
  • UHS has a Debt/Equity ratio of 0.55. This is a neutral value indicating UHS is somewhat dependend on debt financing.
  • UHS has a Debt to Equity ratio of 0.55. This is in the better half of the industry: UHS outperforms 61.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Altman-Z 3.03
ROIC/WACC1.62
WACC7.75%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • UHS has a Current Ratio of 1.05. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
  • UHS's Current ratio of 1.05 is on the low side compared to the rest of the industry. UHS is outperformed by 67.00% of its industry peers.
  • A Quick Ratio of 0.98 indicates that UHS may have some problems paying its short term obligations.
  • UHS has a worse Quick ratio (0.98) than 67.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.98
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

5

3. UHS Growth Analysis

3.1 Past

  • UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.77%, which is quite impressive.
  • UHS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.35% yearly.
  • The Revenue has grown by 9.71% in the past year. This is quite good.
  • UHS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.48% yearly.
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%

3.2 Future

  • Based on estimates for the next years, UHS will show a small growth in Earnings Per Share. The EPS will grow by 7.50% on average per year.
  • UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.27% yearly.
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue Next Year6.52%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y4.27%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

8

4. UHS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.48 indicates a reasonable valuation of UHS.
  • UHS's Price/Earnings ratio is rather cheap when compared to the industry. UHS is cheaper than 96.00% of the companies in the same industry.
  • UHS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • With a Price/Forward Earnings ratio of 7.74, the valuation of UHS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, UHS is valued cheaper than 95.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, UHS is valued rather cheaply.
Industry RankSector Rank
PE 8.48
Fwd PE 7.74
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UHS indicates a somewhat cheap valuation: UHS is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.27
EV/EBITDA 6.09
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • UHS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.88
PEG (5Y)0.59
EPS Next 2Y9.29%
EPS Next 3Y9.15%

5

5. UHS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.43%, UHS is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.50, UHS pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.43, UHS pays less dividend than the S&P500 average, which is at 1.90.
Industry RankSector Rank
Dividend Yield 0.43%

5.2 History

  • The dividend of UHS is nicely growing with an annual growth rate of 32.23%!
  • UHS has paid a dividend for at least 10 years, which is a reliable track record.
  • UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)32.23%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 3.44% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
  • The dividend of UHS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP3.44%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UHS Fundamentals: All Metrics, Ratios and Statistics

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (3/27/2026, 2:29:05 PM)

184.52

-0.57 (-0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-27
Inst Owners97.33%
Inst Owner Change-1.6%
Ins Owners5.83%
Ins Owner Change7.48%
Market Cap11.27B
Revenue(TTM)17.36B
Net Income(TTM)1.49B
Analysts70.37
Price Target252.08 (36.61%)
Short Float %4%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 0.43%
Yearly Dividend0.81
Dividend Growth(5Y)32.23%
DP3.44%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-1.33%
Max EPS beat(2)16.52%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-1.33%
Max EPS beat(4)16.52%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)11
Avg EPS beat(12)9.91%
EPS beat(16)13
Avg EPS beat(16)6.42%
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)2.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)8
Avg Revenue beat(12)0.15%
Revenue beat(16)12
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)-0.28%
EPS NQ rev (1m)1.65%
EPS NQ rev (3m)1.75%
EPS NY rev (1m)0.43%
EPS NY rev (3m)-0.14%
Revenue NQ rev (1m)1.39%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)1.49%
Revenue NY rev (3m)1.49%
Valuation
Industry RankSector Rank
PE 8.48
Fwd PE 7.74
P/S 0.65
P/FCF 13.27
P/OCF 6.05
P/B 1.55
P/tB 3.43
EV/EBITDA 6.09
EPS(TTM)21.76
EY11.79%
EPS(NY)23.86
Fwd EY12.93%
FCF(TTM)13.9
FCFY7.53%
OCF(TTM)30.52
OCFY16.54%
SpS284.25
BVpS119.1
TBVpS53.78
PEG (NY)0.88
PEG (5Y)0.59
Graham Number241.48
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROCE 16.23%
ROIC 12.52%
ROICexc 12.66%
ROICexgc 18.85%
OM 11.48%
PM (TTM) 8.57%
GM N/A
FCFM 4.89%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
ROICexc(3y)10.34%
ROICexc(5y)9.46%
ROICexgc(3y)15.38%
ROICexgc(5y)14.27%
ROCE(3y)13.26%
ROCE(5y)12.14%
ROICexgc growth 3Y22.6%
ROICexgc growth 5Y1.17%
ROICexc growth 3Y23.35%
ROICexc growth 5Y3.38%
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Debt/EBITDA 1.53
Cap/Depr 164.07%
Cap/Sales 5.85%
Interest Coverage 12.78
Cash Conversion 71.36%
Profit Quality 57.04%
Current Ratio 1.05
Quick Ratio 0.98
Altman-Z 3.03
F-Score8
WACC7.75%
ROIC/WACC1.62
Cap/Depr(3y)152.09%
Cap/Depr(5y)148.58%
Cap/Sales(3y)5.67%
Cap/Sales(5y)5.85%
Profit Quality(3y)76.18%
Profit Quality(5y)54.04%
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%
Revenue Next Year6.52%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y4.27%
EBIT growth 1Y18.56%
EBIT growth 3Y25.72%
EBIT growth 5Y7.99%
EBIT Next Year34.17%
EBIT Next 3Y13.52%
EBIT Next 5YN/A
FCF growth 1Y-24.4%
FCF growth 3Y47.99%
FCF growth 5Y-12.18%
OCF growth 1Y-9.81%
OCF growth 3Y23.24%
OCF growth 5Y-4.61%

UNIVERSAL HEALTH SERVICES-B / UHS Fundamental Analysis FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.


How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.44%.